Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Operating Income (2016 - 2025)

Anaptysbio's Operating Income history spans 10 years, with the latest figure at $16.3 million for Q4 2025.

  • For Q4 2025, Operating Income rose 268.17% year-over-year to $16.3 million; the TTM value through Dec 2025 reached -$2.7 million, up 97.61%, while the annual FY2025 figure was -$2.7 million, 97.61% up from the prior year.
  • Operating Income reached $16.3 million in Q4 2025 per ANAB's latest filing, down from $34.7 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $87.9 million in Q4 2023 to a low of -$44.4 million in Q1 2023.
  • Average Operating Income over 5 years is -$16.2 million, with a median of -$26.9 million recorded in 2025.
  • Peak YoY movement for Operating Income: crashed 5115.57% in 2022, then skyrocketed 438.49% in 2023.
  • A 5-year view of Operating Income shows it stood at -$31.2 million in 2021, then rose by 16.64% to -$26.0 million in 2022, then surged by 438.49% to $87.9 million in 2023, then tumbled by 111.0% to -$9.7 million in 2024, then soared by 268.17% to $16.3 million in 2025.
  • Per Business Quant, the three most recent readings for ANAB's Operating Income are $16.3 million (Q4 2025), $34.7 million (Q3 2025), and -$26.2 million (Q2 2025).